Condition: Epilepsy With Uncontrolled Focal-onset Seizures · Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A
The Study is an observational, retrospective study which aim is to assess cenobamate's healthcare resources utilization (HCRU) in the management of uncontrolled focal onset seizures. The amin objective is to compare the resource utilization before and after the use of cenobamate. Data from medical charts will be used and inserted into the eCRF from which the analyses will be conducted. Data from 200 patients from 10 sites in 5 countries are included.
This description comes directly from the study's public registry record.
Lars Nicklasson · +46 702528077 · Lars.nicklasson@angelinipharma.com
Always discuss trial participation with your own doctor first.
| Epilepsiezentrums am Neurozentrum des Universitätsklinikum Freiburg | Freiburg im Breisgau, Germany, Germany | Not Yet Recruiting |
| Epileptologicum | Hamburg, Germany, Germany | Not Yet Recruiting |
| Diakonie Kork, Epilepsiezentrum | Kork, Germany, Germany | Not Yet Recruiting |
| Kempenhaeghe - Academisch Centrum voor Epilepsie | Heeze, Netherlands, Netherlands | Not Yet Recruiting |
| Epilepsy Unit - Neurology Department Valle de Hebron Hospital | Barcelona, Spain, Spain | Recruiting |
| Epilepsy Unit of the Neurology Department of the Hospital Clínico San Carlos | Madrid, Spain, Spain | Recruiting |
| Consorcio Hosp. General Universitario Valencia | Valencia, Spain, Spain | Recruiting |
| Department of Neurology, University Hospital Zurich | Zurich, Switzerland, Switzerland | Recruiting |
| Institute of Neurosciences NHS Greater Glasgow and Clyde | Glasgow, UK, United Kingdom | Recruiting |
| Epilepsies - The Royal Wolverhampton NHS Trust | Wolverhampton, UK, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06922175